To test whether PLD inhibitors affect downstream targets of mTOR, we examined the apoptosis and autophagy pathways after treatment with either PLD inhibitors, 1-BtOH, tert-BtOH or honokiol in ADPKD and OX161 cells. Here, MTOR is linked to autosomal dominant polycystic kidney disease.